Utility of assessing CD3(+) cell chimerism within the first months after allogeneic hematopoietic stem-cell transplantation for acute myeloid leukemia.
- DOI
- 10.1111/tan.14557
- Published
- 2022 Jul
- Container
- HLA
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1111/tan.14557,
title = {Utility of assessing CD3(+) cell chimerism within the first months after allogeneic hematopoietic stem-cell transplantation for acute myeloid leukemia.},
author = {Bendjelloul M and Usureau C and Etancelin P and Saidak Z and Lebon D and Garçon L and Marolleau JP and Desoutter J and Guillaume N},
year = {2022},
journal = {HLA},
doi = {10.1111/tan.14557},
url = {https://doi.org/10.1111/tan.14557}
}RIS
TY - JOUR TI - Utility of assessing CD3(+) cell chimerism within the first months after allogeneic hematopoietic stem-cell transplantation for acute myeloid leukemia. AU - Bendjelloul M AU - Usureau C AU - Etancelin P AU - Saidak Z AU - Lebon D AU - Garçon L AU - Marolleau JP AU - Desoutter J AU - Guillaume N PY - 2022 JO - HLA DO - 10.1111/tan.14557 UR - https://doi.org/10.1111/tan.14557 ER -
APA
M, B., C, U., P, E., Z, S., D, L., L, G., JP, M., J, D., & N, G. (2022). Utility of assessing CD3(+) cell chimerism within the first months after allogeneic hematopoietic stem-cell transplantation for acute myeloid leukemia.. HLA. https://doi.org/10.1111/tan.14557
Source records
- pubmed · retrieved 2026-09-25T09:16:45.350Z